SecBot SecBot
8-K ·Filed May 18, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001104659-26-063267
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This board change is routine and should have no effect on the company's operations or strategy. Monitor for any future material disclosures, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$10.89
T+0 close · May 18, 2026 · via day close
Latest settled
+83.84%
T+60 · $20.02
Vs SPY
+77.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 19 $10.89entry
  2. T+1 · 6mo ago +6.80%α +5.76% · $11.63
  3. T+5 · 6mo ago −0.83%α −3.12% · $10.80
  4. T+20 · 5mo ago +30.12%α +29.13% · $14.17
  5. T+60 · 3mo ago +83.84%α +77.55% · $20.02

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MiniMed disclosed the resignation of director Brett Wall, effective July 3, 2026, due to his departure from parent Medtronic, and the immediate appointment of Medtronic executive Scott Cundy as his replacement. This is a routine board transition with no operational or financial implications.

Key Facts

  • Brett Wall resigned as class II director, effective July 3, 2026; no disagreement with management or board.
  • Scott Cundy appointed as class II director effective July 3, 2026, filling Wall's vacancy; he serves on Nominating and Corporate Governance Committee.
  • Cundy is Senior VP and Chief Quality, Development, and Innovation Officer at Medtronic; he will receive no board compensation while Medtronic is an affiliate.

Financial Impact

No financial impact reported.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-063267
Document: 0001104659-26-063267-index-headers.html0001104659-26-063267
Document: 0001104659-26-063267-index.html0001104659-26-063267
Document: 0001104659-26-063267.txt0001104659-26-063267

Track record

25 reports on MMED

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
  3. Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
  4. Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
  5. Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
  6. Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
  7. Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
  8. Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
  9. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
  10. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026